Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Sales | 5,011 | 6,689 | 4,085 | 4,182 | 2,864 |
| Gross Profit | 5,011 | 6,689 | 4,085 | 4,182 | 2,864 |
| Operating Expenses | 29,533 | 26,697 | 23,277 | 17,412 | 15,417 |
| Operating Income | -24,522 | -20,008 | -19,192 | -13,230 | -12,553 |
| Other Income | 318 | 135 | 675 | 223 | 173 |
| Pre-tax Income | -24,204 | -19,873 | -18,517 | -13,007 | -12,380 |
| Income Tax | 71 | 41 | N/A | -20,587 | 11 |
| Net Income Continuous | -24,275 | -19,914 | -18,517 | 7,580 | -12,391 |
| Net Income | $-24,275 | $-19,914 | $-18,517 | $7,580 | $-12,391 |
| EPS Basic Total Ops | -0.63 | -0.20 | -1.09 | 2.03 | -3.50 |
| EPS Basic Continuous Ops | -0.63 | -0.20 | -1.09 | 2.03 | -3.50 |
| EPS Diluted Total Ops | -0.63 | 0.29 | -1.09 | 1.54 | -3.50 |
| EPS Diluted Continuous Ops | -0.63 | 0.29 | -1.09 | 1.54 | -3.50 |
| EBITDA(a) | $-22,915 | $-19,221 | $-18,562 | $-12,693 | $-12,054 |